Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sevion Therapeutics Inc (OTCQB:SVON)

0.20
Delayed Data
As of Aug 26
 +0.031 / +18.34%
Today’s Change
0.15
Today|||52-Week Range
0.84
-49.87%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Revenue and IncomeNet Revenues37.5K37.5K37.5K0.00
 
 
 
 
Depreciation And Amortization38.1K32.1K30.0K19.0K
 
 
 
 
 
 
Operating ExpensesGross Income-------19.0K
 
 
General Expenses918.4K1.1M965.6K853.1K
 
 
 
 
 
Other Operating Expenses0.0075.0K0.0036.0K
 
 
 
Research And Development841.1K569.5K564.5K557.4K
 
 
 
 
 
Total Operating Expenses956.5K1.2M995.6K908.1K
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-919.0K-1.2M-958.1K-908.1K
 
 
 
 
 
Extraordinary Credit15.7K970.9K0.001.4M
 
 
 
 
Extraordinary Charge--0.00-2.9M-4.0M
 
 
 
Other Expenses-3.5K-282.00-89.000.00
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-906.8K-180.7K-3.9M-3.5M
 
 
 
 
 
Income Taxes0.000.000.00-400.0K
 
 
Preferred Dividend-797.3K-148.4K-14.1K-9.5K
 
 
 
 
 
Net Income-906.8K-180.7K-3.9M-3.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS18.8M20.0M20.4M20.4M
 
 
 
 
 
Shares To Calculate EPS Diluted18.8M20.0M20.4M20.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.09-$0.02-$0.19-$0.15
 
 
 
 
 
EPS Diluted-$0.09-$0.02-$0.19-$0.15